🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Preliminary evidence of improved liver biomarkers in adolescents with obesity and suspected metabolic dysfunction‐associated steatotic liver disease treated with semaglutide: A case series

JPGN Reports(2025)10.1002/jpr3.70131Source: DataRank Database

Preliminary evidence of improved liver biomarkers in adolescents with obesity and suspected metabolic dysfunction‐associated steatotic liver disease treated with semaglutide: A case series is a research paper published in JPGN Reports (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.00)OA: hybridTopics (14)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Katya Fomenko,Fotini T. Mitsinikos,Alaina P. Vidmar ORCID,Rachel B. Schenker ORCID

Live enrichment

PubMed:42110146 PMC:PMC13150997 OpenAlex:https://openalex.org/W7115735451

American Diabetes Association

Grant: #11‐22‐ICTSN‐32

FWCI

0.00

Citation Percentile

0.6%

hybridLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jpr3.70131

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jpr3.70131

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/jpr3.70131

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/jpr3.70131

journalhttps://doi.org/10.1002/jpr3.70131

Fields of Study

Liver Disease Diagnosis and TreatmentDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Keywords

Alanine aminotransferaseSteatosisBody mass indexAlanine transaminaseObesityLiver enzymeFibrosisLiver diseaseFatty liverHepatologyGlp‐1ra

Sustainable Development Goals

SDG 0: Good health and well-being